What is the price of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

The price of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) is $1.15

What is the market cap of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

The market cap of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) is $88.79M

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) Earnings

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

Year	Earnings	Change
Not enough data for the provided dates.

Year

Earnings

Change

Not enough data for the provided dates.

Company	Earnings	Earnings Difference	Country
Royalty Pharma plc RPRX.US	$1.35B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Corcept Therapeutics Incorporated CORT.US	$26.37M	-	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT

Company

Earnings

Earnings Difference

Country